Essential Vitamin · PLP Coenzyme · Amino Acid & Neurotransmitter Metabolism

Vitamin B6

Vitamin B6, active in the body as pyridoxal-5-phosphate (PLP), is a cofactor for roughly 150 enzymes governing amino acid metabolism, neurotransmitter synthesis, and red blood cell formation — one of the most metabolically versatile vitamins in human biology. It's also the supplement on this site with the single strangest safety picture: two major food safety authorities looked at the same underlying risk and landed on official safety limits eight times apart, and both too little and too much of it can cause the exact same nerve damage. That regulatory gap, and what actually happened in the body of research behind it, is covered in full below — along with which of its famous nutrient partnerships hold up and which turn out to be marketing.

1.3mg Adult RDA (19-50)
100mg US Upper Limit
12.5mg EU Upper Limit (2023)
~150 PLP-Dependent Enzymes
Updated
RDA (Adults 19-50) 1.3 mg/day
Tolerable Upper Limit 100 mg/day (US) · 12.5 mg/day (EU)
Primary Sources NIH ODS · NCBI PubMed
Strong Mechanistic & Deficiency-Correction Evidence · A Genuinely Unresolved International Safety Disagreement

Biological Overview

Vitamin B6 is a family of six related water-soluble compounds — pyridoxine, pyridoxal, pyridoxamine, and their phosphorylated forms — that all convert to pyridoxal-5-phosphate (PLP), the active coenzyme used by roughly 150 enzymes throughout the body. PLP-dependent enzymes carry out an outsized share of amino acid metabolism: transamination, decarboxylation, and related reactions that build neurotransmitters, hemoglobin, and DNA precursors, and break down homocysteine. Vitamin B6 is commonly described as "not stored" because it's water-soluble, but that's an oversimplification worth correcting: roughly half the body's total B6 is held in skeletal muscle, bound to the enzyme glycogen phosphorylase, which represents a genuine, if slow-turnover, body reserve rather than an unlimited daily washout. Vitamin B6 is also the subject of a real, current regulatory disagreement between US and EU food safety authorities over exactly how much is too much — addressed in full below rather than glossed over.

Active Coenzyme FormPyridoxal-5-Phosphate (PLP)
PLP-Dependent Enzymes~150, ~4% of classified enzymes
Body Reserve~50% held in muscle glycogen phosphorylase
Strongest EvidenceDeficiency Correction · Pregnancy Nausea

Overview & Classification

Vitamin Class
Water-soluble, B-complex
Six Interconvertible Forms
PL, PN, PM, PLP, PNP, PMP
Active Coenzyme
Pyridoxal-5-Phosphate (PLP)
Adult RDA (19–50)
1.3 mg/day
US Tolerable Upper Limit
100 mg/day
EU Tolerable Upper Limit (2023)
12.5 mg/day
Common Supplement Forms
Pyridoxine HCl, P5P
Unique Safety Profile
Neuropathy at both deficiency and excess

Vitamin B6 Benefits

Every benefit below is backed by an RCT, established biochemistry, or an FDA-approved indication. Vitamin B6's actual relationship with magnesium, zinc, potassium, tyrosine, and lysine is addressed plainly in Nutrient Interactions, below.

🧠
Neurotransmitter Synthesis Strong
Serotonin, dopamine, GABA
  • PLP-dependent decarboxylase enzymes are required to synthesize serotonin from 5-HTP, dopamine from L-DOPA, and GABA from glutamate — three of the central nervous system's primary signaling molecules. [1]
👶
Nausea in Pregnancy Strong
FDA-approved combination product
  • Vitamin B6 alone, and a pyridoxine-doxylamine combination product, are both supported by RCT evidence for reducing nausea and vomiting in pregnancy; the combination product is FDA-approved specifically for this use. [2]
💫
Premenstrual Syndrome Moderate
Modest effect, most trials small/older
  • A meta-analysis of RCTs found vitamin B6 (typically 50–100mg/day) modestly reduced overall PMS symptoms, including depressive symptoms, compared with placebo, though most included trials were small and methodologically dated. [3]
💉
Homocysteine Regulation Strong (Mechanism)
Works alongside B12 and folate
  • PLP is a required cofactor for cystathionine beta-synthase, the enzyme that clears homocysteine via the transsulfuration pathway, complementing the separate B12/folate-dependent remethylation pathway. [4]
  • As with folate (see that page's Clinical Indications), lowering homocysteine has not been reliably shown to reduce cardiovascular events in large trials — the two claims are kept separate here.
Energy Metabolism Strong
Glycogenolysis cofactor
  • PLP is a required cofactor for glycogen phosphorylase, the enzyme that releases glucose from stored muscle and liver glycogen during energy demand — in fact, this single role accounts for roughly half of the body's total vitamin B6 content, held in skeletal muscle. [9]
  • B6 is also required for the broader breakdown of amino acids and fatty acids as alternative energy sources.
🧞
Immune Function Strong
Lymphocyte production & activity
  • Vitamin B6 is required for normal T-lymphocyte development and proliferation, and deficiency measurably impairs immune cell function in controlled feeding studies. [24]
🌜
Sleep & Mood Regulation Mechanistically Supported
Via serotonin and melatonin synthesis
  • Because B6 is required to synthesize serotonin, and serotonin is the direct precursor to melatonin, adequate B6 status supports the biochemical chain behind normal sleep-wake regulation. [1]
  • This is a mechanistic, not a "B6 as sleep aid" claim — direct RCT evidence for B6 supplementation improving sleep specifically in non-deficient people is limited.

Clinical Indications by Evidence Tier

Six specific indications get a closer, more honest look here than a single benefit tile allows — including two where the evidence is genuinely mixed, not uniformly positive.

👶
Doxylamine-Pyridoxine Combination Trials
The Best-Evidenced Use of B6
  • Evidence: randomized trials of a doxylamine-pyridoxine combination (marketed as Diclegis/Diclectin) found significant reduction in nausea and vomiting of pregnancy compared with placebo, leading to FDA approval specifically for this indication. [5]
  • Historical note: a related combination product (Bendectin) was withdrawn from the US market in 1983 amid birth-defect litigation, despite the FDA and multiple later reviews finding no causal evidence of teratogenicity — a case where legal pressure, not scientific evidence, drove a market withdrawal.
🧞
B6-Deficiency Seizures in Infants
A Formula Manufacturing Error, Not a Supplement Story
  • What happened: in the early 1950s, infants fed a commercial formula that had lost most of its vitamin B6 content during autoclave sterilization developed seizures that resolved with B6 supplementation, one of the clearest documented human B6-deficiency syndromes on record. [6]
  • Why it still matters: it's the historical basis for understanding B6's role in GABA synthesis (via glutamate decarboxylase) and remains a reference point in infant formula manufacturing standards.
🦠
Rheumatoid Arthritis
One Positive RCT, One Null RCT
  • Positive result: a 12-week RCT giving RA patients 100mg/day B6 alongside folic acid found significantly reduced IL-6 and TNF-alpha compared with folic acid alone. [25]
  • Null result: a separate double-blind, placebo-controlled trial correcting B6 deficiency in RA patients with 50mg/day pyridoxine restored normal B6 status but found no improvement in inflammatory markers. [26]
  • Honest read: low B6 status is consistently observed in RA, but whether correcting it meaningfully reduces disease activity remains genuinely unsettled.
🪜
B6-Responsive Genetic Conditions
Rare, But the Clearest Medical Indications for B6
  • X-linked sideroblastic anemia: certain genetic mutations affecting ALA synthase (the PLP-dependent, rate-limiting heme synthesis enzyme discussed in Mechanisms, above) respond to high-dose vitamin B6 therapy under hematologist supervision.
  • Pyridoxine-dependent epilepsy: a rare genetic disorder causing seizures in newborns that are specifically and dramatically responsive to high-dose B6, distinct from the historical formula-deficiency seizures described above, which involved no genetic mutation.
Strong Observational Signal, Unconfirmed by Trials

Vitamin B6 and colorectal cancer risk

A 2010 meta-analysis of 13 prospective studies found higher blood PLP levels linearly associated with a 52% lower relative risk of colorectal cancer, and a broader 2017 field synopsis covering 121 observational studies confirmed a consistent inverse relationship between B6 status and several gastrointestinal cancers. [27],[28]

The gap: that same 2017 synopsis, which also pooled nine randomized controlled trials, found the RCT evidence did not support a protective effect of B6 supplementation against cancer, and associations were weaker or null when total intake (food plus supplements) was considered rather than blood PLP level alone. [28] This is a now-familiar pattern on this site: a nutrient's blood level correlating strongly with better outcomes in healthy-population studies, without supplementation itself being confirmed to produce that outcome in a trial — possibly because blood PLP reflects overall diet quality and metabolic health rather than acting as an independent causal factor.

⚠ The carpal tunnel syndrome claim doesn't hold up well

Vitamin B6 has been marketed for carpal tunnel syndrome since the 1970s, based on early observational reports linking low B6 status to the condition. Subsequent placebo-controlled trials have generally failed to show a meaningful benefit of B6 supplementation for carpal tunnel symptoms in people without a diagnosed B6 deficiency. [7] This is a case where an initial correlational observation became a widely repeated consumer claim well past the point the controlled trial evidence supported it.

Mechanisms of Action

Vitamin B6's mechanisms are unusually numerous for a single vitamin, because PLP is a general-purpose amino acid catalyst rather than a cofactor for one specific pathway.

⚖️

Transamination & Decarboxylation

PLP forms a Schiff base with amino acid substrates at an enzyme's active-site lysine, enabling transamination (amino group transfer, the basis of enzymes like ALT and AST) and decarboxylation (carbon dioxide removal, the basis of neurotransmitter synthesis) — the two most common PLP-dependent reaction types. [8]

🧠

Neurotransmitter Decarboxylases

Aromatic L-amino acid decarboxylase (PLP-dependent) converts 5-HTP to serotonin and L-DOPA to dopamine; glutamate decarboxylase (also PLP-dependent) converts glutamate to GABA — the mechanistic basis for B6's role in mood, sleep, and motor regulation. [1]

🥦

Glycogen Phosphorylase — The Body's Largest B6 Reserve

PLP serves a structural, non-catalytic role bound to glycogen phosphorylase in skeletal muscle, which holds roughly half the body's total vitamin B6 — the specific mechanism behind the "B6 is actually stored" correction discussed in Overview, above. [9]

🪜

Heme Synthesis

ALA synthase, the first and rate-limiting enzyme in heme synthesis, is PLP-dependent, linking vitamin B6 status directly to red blood cell formation — severe deficiency can produce a specific microcytic, sideroblastic-pattern anemia. [10]

🔬

The Vitamin B6 Salvage Pathway

All six B6 vitamers are interconverted by a small set of salvage enzymes (pyridoxal kinase, pyridoxine/pyridoxamine 5'-phosphate oxidase), which require riboflavin (as FMN) as a cofactor — the biochemical basis for B6's genuine dependency on adequate riboflavin status. [11]

Dosage & the Two Upper Limits

This is the single most important thing to understand before choosing a B6 dose: the US and EU limits for the same nutrient, based on the same underlying concern, are 8-fold apart.

Life Stage RDA US UL (1998) EU UL (2023)
Adults 19–50 1.3 mg/day 100 mg/day 12.5 mg/day
Adults 51+ (men) 1.7 mg/day 100 mg/day 12.5 mg/day
Adults 51+ (women) 1.5 mg/day 100 mg/day 12.5 mg/day
Pregnancy 1.9 mg/day 100 mg/day 12.5 mg/day
Same Nutrient, Same Concern, Very Different Numbers

Why the US limit is 100mg and the EU limit is 12.5mg

The US Institute of Medicine set its Tolerable Upper Intake Level of 100mg/day in 1998, based on older data suggesting peripheral neuropathy occurred mainly at chronic doses in the hundreds of milligrams. [12] In 2023, following a European Commission request to review several vitamin and mineral upper limits with modern methodology, EFSA identified a reference point of 50mg/day from a case-control study — the Dalton and Dalton 1987 study, which found neuropathy symptoms in women taking doses around 50mg/day — then applied a 4-fold uncertainty factor to account for the wide, unpredictable latency period (1 to 72 months) between starting a dose and symptom onset, arriving at 12.5mg/day. [13]

The honest summary: both bodies are responding to the same real risk — B6-induced peripheral neuropathy — but reached very different numeric conclusions from different underlying data and a different tolerance for uncertainty. Neither number has been shown wrong; they reflect different risk-assessment philosophies applied to a genuinely difficult evidence base, since a clear lowest-observed-effect level in humans has never been firmly established for either side. The practical consequence: many common B-complex supplements and multivitamins, often containing 25–100mg of B6, would be considered well within US guidance but multiple times over the EU's current limit.

Does this mean 50-100mg B6 supplements are dangerous?

Not necessarily, and not definitively safe either — that's precisely the substance of the disagreement. The honest position is that this dose range sits in a genuine gray zone between two legitimate official assessments, not a settled "safe" or "unsafe" verdict either direction.

Why does this matter more for B6 than most vitamins?

Because 50-100mg doses are extremely common in commercial B-complex and stress-support formulations, not an unusual megadose scenario — making this regulatory gap practically relevant to ordinary supplement shopping, not just a technical footnote.

Reading a Vitamin B6 Label

Given the dosage gap above, checking total B6 across every product taken matters more for this vitamin than most.

B6 stacks quietly across multiple products

A B-complex, a multivitamin, a "stress support" formula, and an energy drink can each contain meaningful B6 without any single product looking high-dose.

25mg Typical "B-Complex" product Looks modest on its own — well under the US 100mg limit.
+
+ Multivitamin, Energy Drink, etc. Easily stacks past 12.5mg Combined intake from several ordinary products can exceed the EU's 12.5mg limit well before approaching the US 100mg ceiling.

Quick reference: checking your total B6

Add up B6 (listed as pyridoxine HCl or as P5P/pyridoxal-5-phosphate) from every daily supplement, fortified food, and energy product, not just the one labeled "B6" or "B-complex" — this is the only reliable way to know where total intake actually sits relative to either the 100mg US or 12.5mg EU reference points discussed above.

Pyridoxine vs. P5P

P5P's theoretical advantage is real chemistry, but almost all of vitamin B6's clinical trial evidence — including for the two best-established uses on this page — was built using standard pyridoxine, not P5P.

Form Chemistry Conversion Needed Evidence Base Cost
Pyridoxine HCl The standard, most common supplement salt form Must be converted to PLP via the liver salvage pathway (requires riboflavin as a cofactor) Used in essentially all major RCTs, including morning sickness and PMS trials [2],[3] Lowest
P5P (Pyridoxal-5-Phosphate) The active coenzyme form itself None — already active, bypasses the liver conversion step Theoretical bioavailability advantage; not directly tested against the same clinical outcomes as pyridoxine [14] Higher

The practical takeaway

For most people, standard pyridoxine remains the best-evidenced choice simply because it's what the clinical trials used. P5P is a reasonable option for people with a specific reason to bypass hepatic conversion (significant liver impairment, for example), but "more bioactive" on paper hasn't been shown to translate into better outcomes for the uses this page covers, and marketing claims that P5P is categorically safer at high doses aren't well established either — both forms are subject to the same underlying neuropathy risk discussed in Safety, below.

Nutrient–Nutrient Interactions

Vitamin B6's real nutrient dependencies run mostly in the opposite direction from how they're often marketed: B6 needs riboflavin, niacin, and zinc to become active, more than it independently "boosts" other nutrients.

Nutrient Interaction Type Mechanism Clinical Relevance Evidence Quality
Riboflavin (B2) B6 Depends on B2 The salvage enzyme that converts pyridoxine to active PLP requires FMN, a riboflavin-derived cofactor — genuine dependency in the opposite direction from how B6 is often marketed. [11] Moderate: relevant to why B-complex formulations bundle B2 and B6 together. Established enzyme biochemistry
Niacin (B3) Bidirectional B6 is required to convert dietary tryptophan into niacin, while adequate niacin status supports the broader B-vitamin metabolic network B6 operates within. [15] Moderate: relevant mainly in combined-deficiency states, uncommon with adequate diet. Established biochemistry
Zinc B6 Depends on Zinc Zinc is a required cofactor for the hepatic conversion of pyridoxine to its active form, a dependency running opposite to claims that B6 is "necessary for zinc metabolism." [16] Low-Moderate: relevant mainly in combined nutritional deficiency, not a typical single-nutrient concern. Established biochemistry
Magnesium Real Chemistry, Overstated Marketing An in vitro study found PLP, but not other B6 forms, can form a chemical complex with magnesium, suggesting a plausible transport-facilitation role. [17] Low: specific figures circulating online (20-40% absorption increases) do not trace back to any verifiable human trial and should not be treated as established. Single in vitro study; no confirmed human bioavailability data
Vitamin B12 & Folate (B9) Complementary All three vitamins participate in homocysteine metabolism through separate but connected pathways — B6 via transsulfuration, B12/folate via remethylation. [4] Moderate: the basis for combined B-vitamin homocysteine research discussed in Benefits, above. Established biochemistry
Two Claims That Didn't Verify

"B6 improves potassium and tyrosine bioavailability" and "favors lysine absorption"

No primary literature was found supporting vitamin B6 improving potassium bioavailability, tyrosine bioavailability, or lysine absorption specifically. B6 does participate in tyrosine metabolism — PLP-dependent enzymes are involved in tyrosine's breakdown and its conversion toward dopamine and norepinephrine — but that's a metabolic role, not an absorption-enhancing one, and it isn't the same claim as improving tyrosine's bioavailability from food.

For potassium and lysine specifically, no absorption-related mechanism connecting them to vitamin B6 was found in primary literature at all. These read as generalized "vitamin B6 helps with everything" claims rather than specific, checkable mechanisms, and are left out of this page's nutrient interaction table rather than repeated without support.

Who Needs Vitamin B6 Most

True deficiency is uncommon with a varied diet, but several groups have a specific, well-documented elevated need or risk.

Life-Stage-Linked

Pregnant Women With Nausea

The population with the strongest, most direct clinical trial evidence for B6, alone or combined with doxylamine. [2],[5]

Treatment-Linked

People on Isoniazid or Levodopa

Isoniazid depletes B6 and often requires co-prescribed supplementation; levodopa's effectiveness can be reduced by B6, requiring careful, medically-guided dosing (see Drug Interactions, below).

Condition-Linked

People With Malabsorptive Conditions

Celiac disease, Crohn's disease, ulcerative colitis, and other malabsorptive autoimmune disorders are associated with low plasma PLP by mechanisms not yet fully understood. [18]

Lifestyle-Linked

People With Alcohol Use Disorder

Chronic alcohol consumption accelerates PLP breakdown and is one of the most consistent causes of low B6 status. [19]

Condition-Linked

Chronic Kidney Disease / Hemodialysis Patients

Dialysis removes water-soluble vitamins including B6, making this a recognized, monitored deficiency-risk population in nephrology care.

Diet-Linked

People Taking Multiple B-Complex-Containing Products

Not a deficiency-risk group, but the population most likely to unknowingly stack B6 past the EU reference point discussed in Dosage, above — worth checking total intake, not a specific supplementation need.

Drug Interactions

Vitamin B6 has an unusually high number of clinically relevant drug interactions for a vitamin, running in both directions.

Drug / Drug Class Direction Recommendation
Levodopa (without carbidopa) B6 reduces drug effectiveness B6 accelerates peripheral breakdown of levodopa before it reaches the brain; this interaction is largely neutralized when levodopa is combined with carbidopa, as in most modern Parkinson's formulations, but remains relevant with levodopa alone. [20]
Isoniazid, hydralazine, cycloserine, penicillamine Deplete/antagonize B6 These drugs bind or interfere with B6 vitamers, often requiring co-prescribed B6 supplementation as standard practice. [21]
Antiepileptic drugs (carbamazepine, phenytoin) Increase B6 catabolism Can lower plasma PLP and raise homocysteine, potentially affecting seizure control; monitored by prescribing physicians. [22]
Oral contraceptives & estrogen therapy May increase B6 requirement Associated with modestly lower B6 status in some studies; not typically requiring specific supplementation without other risk factors.
Theophylline May increase B6 requirement Associated with lower B6 status with chronic use; relevant mainly to long-term asthma/COPD management.

Safety & Neuropathy Risk

🚫

When to Use Caution

  • Doses above the EU's 12.5mg/day reference point on an ongoing basis: discussed fully in Dosage above — not proven dangerous, but sitting in a genuine, unresolved gray zone. [13]
  • Taking levodopa without carbidopa: B6 can reduce the drug's effectiveness (see Drug Interactions, above).
  • Any unexplained tingling or numbness in the hands or feet while taking B6, regardless of dose — this warrants medical evaluation rather than assuming it isn't B6-related.
  • Multiple combined B6-containing products: check total daily intake across all supplements and fortified foods, not just one label.
⚠️

Peripheral Neuropathy — At Both Ends of the Range

  • The unusual pattern: both vitamin B6 deficiency and vitamin B6 excess can independently cause peripheral neuropathy — tingling, numbness, and coordination problems in the hands and feet. [23]
  • Case-report evidence: the Dalton and Dalton 1987 study, central to the EFSA reassessment, described neuropathy symptoms in women taking around 50mg/day over extended periods. [13]
  • Latency is unpredictable: symptom onset in documented case reports has ranged from 1 to 72 months after starting a given dose, which is part of why establishing a precise safety threshold has proven so difficult for both regulatory bodies. [13]
  • Generally reversible: most reported cases of B6-induced neuropathy improve after stopping supplementation, though recovery isn't guaranteed or always complete.
Medical disclaimer: This reference is for educational purposes only and does not constitute medical advice, diagnosis, or treatment guidance. Vitamin B6 has a genuinely disputed safety threshold between major regulatory bodies, and both deficiency and excess can cause nerve damage. Anyone experiencing tingling or numbness, taking levodopa, or considering long-term doses above 12.5mg/day should consult a qualified healthcare provider.

Vitamin B6 FAQ

Answers to the specific dosing, safety, and interaction questions most often raised about vitamin B6.

Why does Europe's vitamin B6 safety limit differ so much from the US limit?
EFSA revised its 2023 upper limit to 12.5mg/day based on a case-control study and case reports of neuropathy at lower doses than previously assumed. [13] The US limit remains 100mg/day, from 1998 data. Both address the same neuropathy risk with different evidence and methodology.
Does vitamin B6 really improve magnesium absorption?
The evidence is much thinner than commonly claimed. One in vitro study found PLP can chemically complex with magnesium, but specific figures like "20-40% increased absorption" circulating online don't trace to any verifiable human trial. [17]
Is vitamin B6 effective for morning sickness in pregnancy?
Yes — one of B6's best-established uses. Both B6 alone and a pyridoxine-doxylamine combination product are supported by RCTs, with the combination FDA-approved specifically for this indication. [2],[5]
What's the difference between pyridoxine and P5P supplements?
Pyridoxine is the standard, cheaper form requiring liver conversion to the active PLP coenzyme; P5P is already active. Nearly all clinical trial evidence used pyridoxine, so P5P's theoretical bioavailability edge hasn't been tested against the same outcomes. [14]
Can too little and too much vitamin B6 cause the same symptoms?
Yes — both deficiency and excess can independently cause peripheral neuropathy, an unusual pattern among vitamins. [23] This is why blood testing, not guessing, is the appropriate way to evaluate suspected B6-related neuropathy.

Bibliography

Numbered references for every claim made on this page, drawn from peer-reviewed literature, NIH fact sheets, and the EFSA scientific opinion.

1. Linus Pauling Institute, Oregon State University. Vitamin B6 — Micronutrient Information Center (neurotransmitter synthesis). LPI →
2. Office of Dietary Supplements, NIH. Vitamin B6 — Fact Sheet for Health Professionals (nausea in pregnancy). NIH ODS →
3. Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318(7195):1375–1381. PubMed →
4. Cystathionine beta-synthase and PLP-dependent homocysteine transsulfuration. Standard biochemistry literature, cited in NIH ODS. Cited in NIH ODS →
5. Koren G, Clark S, Hankins GD, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2010. PubMed →
6. Coursin DB. Convulsive seizures in infants with pyridoxine-deficient diet. JAMA. 1954;154(5):406–408. Cited in NIH ODS →
7. Vitamin B6 and carpal tunnel syndrome: controlled trial evidence review. Cited in NIH ODS Health Professional Fact Sheet. Cited in NIH ODS →
8. PLP-dependent enzyme catalytic mechanism (Schiff base formation). PMC. PMC9820991 →
9. PLP as a structural cofactor of glycogen phosphorylase; muscle as the primary B6 reserve. Standard biochemistry literature. PMC2443152 →
10. ALA synthase, PLP dependence, and sideroblastic anemia. Standard hematology biochemistry literature, cited in NIH ODS. Cited in NIH ODS →
11. Pyridoxamine phosphate oxidase — FMN/riboflavin dependence in the B6 salvage pathway. ScienceDirect Topics. ScienceDirect →
12. Institute of Medicine (National Academies). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998 UL of 100mg/day). NCBI Bookshelf →
13. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific opinion on the tolerable upper intake level for vitamin B6. EFSA Journal. 2023;21(5):e08006. PubMed →
14. Bioavailability and clinical trial usage patterns of pyridoxal-5-phosphate versus pyridoxine. Cited in NIH ODS Health Professional Fact Sheet. Cited in NIH ODS →
15. Tryptophan-to-niacin conversion pathway and B6 dependence. Standard nutritional biochemistry literature, cited in NIH ODS. Cited in NIH ODS →
16. Zinc-dependent hepatic conversion of pyridoxine to pyridoxal. Standard nutritional biochemistry literature. Cited in NIH ODS →
17. In vitro evidence for a relationship between magnesium and vitamin B-6. PubMed PMID: 2133627 →
18. Office of Dietary Supplements, NIH. Vitamin B6 — Health Professional Fact Sheet (malabsorptive autoimmune disorders and low PLP). NIH ODS →
19. Office of Dietary Supplements, NIH. Vitamin B6 — Health Professional Fact Sheet (alcohol dependence and low PLP). NIH ODS →
20. Office of Dietary Supplements, NIH. Vitamin B6 — Health Professional Fact Sheet (levodopa interaction, carbidopa exception). NIH ODS →
21. Office of Dietary Supplements, NIH. Vitamin B6 — Health Professional Fact Sheet (isoniazid, hydralazine, cycloserine, penicillamine interactions). NIH ODS →
22. Antiepileptic drugs, vitamin B6 catabolism, and hyperhomocysteinemia. Cited in NIH ODS Health Professional Fact Sheet. Cited in NIH ODS →
23. Vrolijk MF, Opperhuizen A, Jansen EHJM, Hageman GJ, Bast A, Haenen GRMM. The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol In Vitro. 2017;44:206–212. PubMed →
24. Office of Dietary Supplements, NIH. Vitamin B6 — Fact Sheet for Health Professionals (immune function, T-lymphocyte development). NIH ODS →
25. Huang SC, Wei JC, Wu DJ, Huang YC. Vitamin B6 supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis. Eur J Clin Nutr. 2010;64:1007–1013. Nature →
26. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. PMC. PMC1297588 →
27. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA. 2010;303(11):1077–1083. PubMed →
28. Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. J Natl Cancer Inst. 2017;109(3):djw230. PubMed →

Additional Reference Literature

Office of Dietary Supplements, NIH. Vitamin B6 — Consumer Fact Sheet. Plain-language overview of intake, food sources, and safety. NIH ODS →
Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76(1):8–11. The foundational case-control study behind the EFSA reassessment.
Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983;309(8):445–448. Original high-dose B6 neuropathy case series.
Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press. Basis for current US RDA and UL values.

Related

  • Magnesium Glycinate — the nutrient at the center of this page's most-corrected marketing claim
  • Vitamin B9 (Folate) — B6's direct partner in homocysteine metabolism
  • Zinc — a required cofactor for activating vitamin B6, not the reverse